Impact BioMedical Inc. (IBO) stock
IBONYSEPharmaceutical PreparationsFiscal year ends December 31
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026Market cap $26.14MP/E –Yield –
Impact BioMedical cash
Cash and short-term investments held at the end of each period.
Impact BioMedical's cash was $21.00K at Sep 30, 2026. For fiscal 2025 it was $3.00K, down 99.8% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.00K | -99.8% |
| FY2024 | Dec 31, 2024 | $2.00M | +199800.0% |
| FY2023 | Dec 31, 2023 | $1.00K | -50.0% |
| FY2022 | Dec 31, 2022 | $2.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $21.00K | +75.0% |
| Q2 FY2026 | Jun 30, 2026 | $10.00K | -98.4% |
| Q1 FY2026 | Mar 31, 2026 | $20.00K | -98.5% |
| Q4 FY2025 | Dec 31, 2025 | $3.00K | -99.8% |
| Q3 FY2025 | Sep 30, 2025 | $12.00K | -99.6% |
| Q2 FY2025 | Jun 30, 2025 | $624.00K | +31100.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.32M | +65800.0% |
| Q4 FY2024 | Dec 31, 2024 | $2.00M | +199800.0% |
| Q3 FY2024 | Sep 30, 2024 | $2.67M | +1227.4% |
| Q2 FY2024 | Jun 30, 2024 | $2.00K | -33.3% |
| Q1 FY2024 | Mar 31, 2024 | $2.00K | 0.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $201.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $3.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $2.00K | – |
See a number that looks wrong?